We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+5.63%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$406M
AUM Growth
-$32.3M
Cap. Flow
-$132M
Cap. Flow %
-32.56%
Top 10 Hldgs %
49.27%
Holding
151
New
39
Increased
19
Reduced
25
Closed
51

Top Buys

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$31.3M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$19.6M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$7.25M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$6.43M
5
AGN
Allergan Inc
AGN
+$6.23M

Top Sells

Rank Stock Value
1
SMMF
Summit Financial Group, Inc.
SMMF
+$116M
2
GSK icon
GSK
GSK
+$19M
3
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$15.2M
4
LLY icon
Eli Lilly
LLY
+$11.9M
5
SNY icon
Sanofi
SNY
+$10.6M

Sector Composition

Rank Sector Weight
1 Healthcare 73.98%
2 Technology 4.07%
3 Consumer Discretionary 3.5%
4 Industrials 2.92%
5 Communication Services 1.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VYX icon
126
NCR Voyix
VYX
$1.14B
– –
-77,979
Closed -$1.75M
XLE icon
127
State Street Energy Select Sector SPDR ETF
XLE
$39.6B
– –
-80,000
Closed -$3.56M
XLF icon
128
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
– –
-775,370
Closed -$15.2M
XLI icon
129
State Street Industrial Select Sector SPDR ETF
XLI
$32.8B
– –
-54,623
Closed -$2.86M
XNCR icon
130
Xencor
XNCR
$1.5B
– –
-100,000
Closed -$1.17M
XNTK icon
131
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.06B
– –
-5,600
Closed -$3.62M
IRD
132
Opus Genetics
IRD
$306M
– –
-4,180
Closed -$2.17M
CDMO
133
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
– –
-91,429
Closed -$1.22M
SRCL
134
DELISTED
Stericycle Inc
SRCL
– –
-9,439
Closed -$1.07M
IMGN
135
DELISTED
Immunogen Inc
IMGN
– –
-34,500
Closed -$515K
FRTX
136
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
– –
-95
Closed -$387K
ALBO
137
DELISTED
Albireo Pharma Inc
ALBO
– –
-9,463
Closed -$775K
HSTO
138
DELISTED
Histogen Inc. Common Stock
HSTO
– –
-400
Closed -$651K
XLRN
139
DELISTED
Acceleron Pharma
XLRN
– –
-20,000
Closed -$690K
FLXN
140
DELISTED
Flexion Therapeutics, Inc.
FLXN
– –
-103,955
Closed -$1.71M
FPRX
141
DELISTED
Five Prime Therapeutics, Inc.
FPRX
– –
-90,000
Closed -$1.77M
QLTI
142
DELISTED
QLT Inc
QLTI
– –
-200,000
Closed -$1.11M
TBRA
143
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
– –
-22,222
Closed -$2.5M
RLYP
144
DELISTED
RELYPSA INC COM
RLYP
– –
-47,300
Closed -$1.41M
PCP
145
DELISTED
PRECISION CASTPARTS CORP
PCP
– –
-12,520
Closed -$3.17M
LMNS
146
DELISTED
LUMENIS LTD CL B ORD SHS (ISR)
LMNS
$0 ﹤0.01%
+245
New +$2.28K
CTIC
147
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
– –
-40,000
Closed -$1.36M
2 3 4 5
6

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q2 2014 Portfolio in Review

As of Q2 2014, Sphera Funds Management held 151 positions worth $406M, down 7.4% from $438M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Sphera Funds Management withdrew a net $132M in Q2 2014, closing 51 positions and reducing 25 holdings. Its most notable exit was State Street Financial Select Sector SPDR ETF, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, up from 74% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Sphera Funds Management opened a new position in Shire pic worth $14.1M.

  • Sphera Funds Management's largest Q2 2014 buy was Shire pic: 180,000 shares worth $14.1M.
  • Sphera Funds Management added most to Teva Pharmaceuticals in Q2 2014, an estimated $19.6M increase.
  • Sphera Funds Management's biggest Q2 2014 reduction was Summit Financial Group, Inc., cutting an estimated $116M.
  • Sphera Funds Management fully exited State Street Financial Select Sector SPDR ETF in Q2 2014, selling an estimated $15.2M.
  • Sphera Funds Management's ten largest holdings make up 49% of its $406M portfolio in Q2 2014.
  • Sphera Funds Management opened 39 new positions and closed 51 in Q2 2014.
  • Sphera Funds Management's portfolio value fell 7.4% quarter-over-quarter to $406M.

Based on Sphera Funds Management's 13F filing for Q2 2014, filed 11 Aug 2014.